Long-Term Outcome in Levothyroxine Treated Patients With Subclinical Hypothyroidism and Concomitant Heart Disease.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  2016-08-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/JC.2016-2226PMID 27571183
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The impact of thyroid hormone replacement therapy on left ventricular diastolic function in patients with subclinical hypothyroidism

  2016influential reference
• Long‐term L‐Triiodothyronine (T3) treatment in stable systolic heart failure patients: a randomised, double‐blind, cross‐over, placebo‐controlled intervention study

  2015cited by this paper
• Thyroxine in acute myocardial infarction (ThyrAMI) - levothyroxine in subclinical hypothyroidism post-acute myocardial infarction: study protocol for a randomised controlled trial

  2015cited by this paper
• Subclinical and overt thyroid dysfunction and risk of all-cause mortality and cardiovascular events: a large population study.

  2014cited by this paper
• The Dilemma of Treating Subclinical Hypothyroidism: Risk that Current Guidelines Do More Harm than Good

  2014cited by this paper
• Cardiovascular disease and thyroid function.

  2014cited by this paper
• Persistence of Mortality Risk in Patients With Acute Cardiac Diseases and Mild Thyroid Dysfunction

  2012cited by this paper
• Mechanisms in endocrinology: Heart failure and thyroid dysfunction.

  2012cited by this paper
• Levothyroxine treatment of subclinical hypothyroidism, fatal and nonfatal cardiovascular events, and mortality.

  2012influential reference
• The natural history of subclinical hypothyroidism in the elderly: the cardiovascular health study.

  2012cited by this paper
• The Danish National Prescription Registry

  2011cited by this paper
• The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients

  2011cited by this paper
• The Danish Register of Causes of Death

  2011cited by this paper
• The Danish National Patient Register

  2011influential reference
• The Danish Civil Registration System

  2011cited by this paper
• Danish registers on personal income and transfer payments

  2011cited by this paper
• Thyroid Replacement Therapy and Heart Failure

  2010cited by this paper
• Subclinical hypothyroidism and the risk of coronary heart disease and mortality.

  2010cited by this paper
• The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham Survey cohort.

  2010influential reference
• Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis.

  2008cited by this paper
• The pattern of use of non‐steroidal anti‐inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million people

  2008cited by this paper
• Age–period–cohort models for the Lexis diagram

  2007cited by this paper
• Association between increased mortality and mild thyroid dysfunction in cardiac patients.

  2007cited by this paper
• Risk of Death or Reinfarction Associated With the Use of Selective Cyclooxygenase-2 Inhibitors and Nonselective Nonsteroidal Antiinflammatory Drugs After Acute Myocardial Infarction

  2006cited by this paper
• Charlson scores based on ICD-10 administrative data were valid in assessing comorbidity in patients undergoing urological cancer surgery.

  2006cited by this paper
• Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans.

  2005cited by this paper
• Subclinical thyroid dysfunction as a risk factor for cardiovascular disease.

  2005cited by this paper
• Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism.

  2004cited by this paper
• Subclinical hypothyroidism: the case for treatment.

  2003cited by this paper
• Subclinical hypothyroidism: the case against treatment.

  2003cited by this paper
• Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).

  2002cited by this paper
• Subclinical Hypothyroidism: A Misnomer in Search of a New Name

  2001cited by this paper
• Serum thyroid-stimulating hormone measurement for assessment of thyroid function and disease.

  2001influential reference
• Subclinical Hypothyroidism Is an Independent Risk Factor for Atherosclerosis and Myocardial Infarction in Elderly Women: The Rotterdam Study

  2000cited by this paper
• Effect of thyroid substitution on hypercholesterolaemia in patients with subclinical hypothyroidism: a reanalysis of intervention studies

  1996cited by this paper
• Elevated serum lipoprotein(a) in subclinical hypothyroidism

  1995cited by this paper
• Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine.

  1994cited by this paper
• Usefulness of L-thyroxine to improve cardiac and exercise performance in idiopathic dilated cardiomyopathy.

  1994cited by this paper
• Cardiac Effects of Long Term Thyrotropin-Suppressive Therapy with Levothyroxine*

  1993cited by this paper
• Grades of hypothyroidism.

  1973cited by this paper
• Subclinical

  1966cited by this paper
• E-mail Karger@karger.com Guidelines 2013 Eta Guideline: Management of Subclinical Hypothyroidism

  year unknowncited by this paper

• Risk factors and clinical implications of thyroxine replacement therapy on major adverse cardiovascular events in type 2 diabetes: a retrospective cohort study

  2026cites this paper
• Hypothyroidism: playing the cardiometabolic risk concerto

  2025cites this paper
• Effect of levothyroxine on major adverse cardiovascular events in patients with hypothyroidism and cardiovascular disease

  2025cites this paper
• Is subclinical hypothyroidism associated with cardiovascular disease in the elderly?

  2025cites this paper
• Subclinical hypothyroidism and cardiovascular diseases: Pathogenetic mechanisms and clinical implications

  2025cites this paper
• Efficacy and safety of levothyroxine monotherapy in lowering the risk of cardiovascular disease in older adults with subclinical hypothyroidism: research protocols of a multicenter, open-label, randomized controlled trial

  2025cites this paper
• Dyslipidémies secondaires

  2024cites this paper
• Hypothyroidism and metabolic cardiovascular disease

  2024cites this paper
• Determinants for Thyroid Hormone Replacement Therapy in Subclinical Hypothyroidism: A Multicenter Electronic Health Records-Based Study

  2023cites this paper
• Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022

  2023cites this paper
• Interplay between cardiovascular and thyroid dysfunctions: A review of clinical implications and management strategies

  2022cites this paper
• Effect of Levothyroxine on Older Patients With Subclinical Hypothyroidism: A Systematic Review and Meta-Analysis

  2022cites this paper
• Approach to adult patients with primary hypothyroidism in some special situations: a position statement from the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism (SBEM)

  2022cites this paper
• The Effect of Thyroxine Therapy on Cardiovascular Risk Factors in Patients with Subclinical Hypothyroidism

  2021cites this paper
• Levothyroxine and the Heart

  2021cites this paper
• Sociodemographic Disparities in the Treatment of Hypothyroidism: NHANES 2007–2012

  2021cites this paper
• Secondary dyslipidemia: its treatments and association with atherosclerosis.

  2021cites this paper
• A protocol for systematic review and meta-analysis

  2021cites this paper
• Efficacy and safety of thyroxine therapy on patients with heart failure and subclinical hypothyroidism

  2021cites this paper
• Subclinical hypothyroidism in older individuals.

  2021cites this paper
• Influence of the statin therapy on cardiovascular remodeling in arterial hypertension, combined with subclinical hypothyroidism

  2020cites this paper
• Subclinical thyroid dysfunction and cardiovascular consequences: An alarming wake-up call?

  2020cites this paper
• Efficacy of Levothyroxine Therapy on Diastolic Dysfunction in Patients with Subclinical Hypothyroidism

  2020cites this paper
• Subclinical hypothyroidism: To treat or not to treat?

  2020cites this paper
• TAK1-AMPK Pathway in Macrophages Regulates Hypothyroid Atherosclerosis

  2020cites this paper
• Levothyroxine for the Treatment of Subclinical Hypothyroidism and Cardiovascular Disease

  2020cites this paper
• Association of Thyroid Hormone Therapy with Mortality in Subclinical Hypothyroidism: A Systematic Review and Meta-analysis.

  2020cites this paper
• Subclinical hypothyroidism and metabolic syndrome: reasons for drug intervention

  2020cites this paper
• Clinical Outcomes After Discontinuation of Thyroid Hormone Replacement: A Systematic Review and Meta-Analysis

  2020cites this paper
• A practical contemporary approach to decision-making on subclinical hypothyroidism

  2020cites this paper
• Correlation of GLUT1 and GLUT4 with prognosis of patients with hypothyroidism and cardiac insufficiency.

  2020cites this paper
• The impact of subclinical hypothyroidism on long-term outcomes in older patients undergoing percutaneous coronary intervention

  2020cites this paper
• Effect of levothyroxine on cardiac function in children with subclinical hypothyroidism: A quasi-experimental study

  2019cites this paper
• Recommendation on screening adults for asymptomatic thyroid dysfunction in primary care

  2019cites this paper
• Screening for thyroid dysfunction and treatment of screen-detected thyroid dysfunction in asymptomatic, community-dwelling adults: a systematic review

  2019cites this paper
• Особенности кардиоваскулярного ремоделирования у больных гипертонической болезнью высокого дополнительного риска с сопутствующим субклиническим гипотиреозом

  2019cites this paper
• Thyroid hormone therapy for subclinical hypothyroidism

  2019cites this paper
• Over- and Under-Treatment of Hypothyroidism Is Associated with Excess Mortality: A Register-Based Cohort Study

  2018cites this paper
• Mujer, corazón y tiroides

  2018cites this paper
• Can We Link Thyroid Status, Energy Expenditure, and Body Composition to Management of Subclinical Thyroid Dysfunction?

  2018cites this paper
• THYROID HORMONE REPLACEMENT REDUCES THE RISK OF CARDIOVASCULAR DISEASES IN DIABETIC NEPHROPATHY PATIENTS WITH SUBCLINICAL HYPOTHYROIDISM.

  2018cites this paper
• Subclinical hypothyroidism: Should we treat?

  2017cites this paper
• Subclinical thyroid dysfunction and risk of carotid atherosclerosis

  2017cites this paper
• MECHANISMS IN ENDOCRINOLOGY: Aging and anti-aging: a Combo-Endocrinology overview.

  2017cites this paper
• Aging and Anti-aging Endocrinology : A Combo Overview

  2017cites this paper
• E�cacy and safety of LT4 monotherapy in lowering the risk of cardiovascular disease in older adults with subclinical hypothyroidism: research protocols of a multi-center, open label, randomized controlled trial

  year unknowncites this paper